Virus-like particle

May 11, 2020

Portage Makes Additional Investment in Stimunity S.A.S, a Paris-Based Cancer Immunotherapy Company.

Apr 21, 2020

Clinical Trials for COVID-19 Treatments or Vaccines Reaching Unprecedented Levels

Mar 12, 2020

Medicago announces production of a viable vaccine candidate for COVID-19

Oct 01, 2019

Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine

Jun 10, 2019

Technologies Enabling Next Generation Vaccine Development, 2019 - Upcoming Vaccine Technologies for Infectious Diseases

May 27, 2019

Technologies Enabling Next Generation Vaccine Development

Feb 04, 2019

VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine

Dec 12, 2018

GHIT Fund Announces New Investments in Vaccines for Dengue and Leishmaniasis, and Drug Screening for Malaria and Tuberculosis

Jun 04, 2018

Portage provides update on its associate, Stimunity S.A, a Paris-based cancer immunotherapy company

Sep 26, 2017

Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine

Jul 21, 2017

VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer